Search Articles

View query in Help articles search

Search Results (1 to 10 of 189 Results)

Download search results: CSV END BibTex RIS


Public Disclosure of Results From Artificial Intelligence/Machine Learning Research in Health Care: Comprehensive Analysis of ClinicalTrials.gov, PubMed, and Scopus Data (2010-2023)

Public Disclosure of Results From Artificial Intelligence/Machine Learning Research in Health Care: Comprehensive Analysis of ClinicalTrials.gov, PubMed, and Scopus Data (2010-2023)

Clearly, significant challenges exist even before introducing the added complexities of multicenter studies, which involve substantial clustering (eg, across multiple centers, regions, or countries) and require more rigorous design, analysis, and reporting methods compared to standard prediction model studies [50].

Shoko Maru, Ryohei Kuwatsuru, Michael D Matthias, Ross J Simpson Jr

J Med Internet Res 2025;27:e60148

Assessing the Diagnostic Accuracy of ChatGPT-4 in Identifying Diverse Skin Lesions Against Squamous and Basal Cell Carcinoma

Assessing the Diagnostic Accuracy of ChatGPT-4 in Identifying Diverse Skin Lesions Against Squamous and Basal Cell Carcinoma

The model showed significant bias in SCC classification, frequently misclassifying SCC as BCC with a high rate of false-positive results. This aligns with previous research that observed SCC is often mistaken for BCC, particularly when features like pigmentation or rolled borders overlap [8]. Chat GPT’s performance worsened in Prompt 2, where SCC was frequently misclassified as AK.

Nitin Chetla, Matthew Chen, Joseph Chang, Aaron Smith, Tamer Rajai Hage, Romil Patel, Alana Gardner, Bridget Bryer

JMIR Dermatol 2025;8:e67299

ChatGPT’s Performance on Portuguese Medical Examination Questions: Comparative Analysis of ChatGPT-3.5 Turbo and ChatGPT-4o Mini

ChatGPT’s Performance on Portuguese Medical Examination Questions: Comparative Analysis of ChatGPT-3.5 Turbo and ChatGPT-4o Mini

Chat GPT, the large language model (LLM) chatbot, developed by Open AI [4], that started the AI boom in November 2022, became the most popular AI tool of 2023, accounting for over 60.2% of visits between September 2022 and August 2023, with a total of 14.6 billion website visits [5].

Filipe Prazeres

JMIR Med Educ 2025;11:e65108

An AI-Based Clinical Decision Support System for Antibiotic Therapy in Sepsis (KINBIOTICS): Use Case Analysis

An AI-Based Clinical Decision Support System for Antibiotic Therapy in Sepsis (KINBIOTICS): Use Case Analysis

A 2-stage base model (random forest at both stages) was developed for the initial therapy using patient data, laboratory data, and clinical data. Subsequently, the model was optimized using a variety of parameters, including the number of decision trees and tree depth (the model specifications and results will be published separately once the AI-based CDSS model has been finalized).

Juliane Andrea Düvel, David Lampe, Maren Kirchner, Svenja Elkenkamp, Philipp Cimiano, Christoph Düsing, Hannah Marchi, Sophie Schmiegel, Christiane Fuchs, Simon Claßen, Kirsten-Laura Meier, Rainer Borgstedt, Sebastian Rehberg, Wolfgang Greiner

JMIR Hum Factors 2025;12:e66699

Peer Review for “Checklist Approach to Developing and Implementing AI in Clinical Settings: Instrument Development Study”

Peer Review for “Checklist Approach to Developing and Implementing AI in Clinical Settings: Instrument Development Study”

Additionally, while the CASo F checklist is a valuable tool, it would benefit from a more detailed comparison to established frameworks like TRIPOD (Transparent Reporting of a Multivariable Prediction Model for individual Prognosis or Diagnosis), which has been widely used in developing and validating clinical prediction models. Discussing how the CASo F complements or improves upon TRIPOD would strengthen the paper’s contributions.

Anonymous

JMIRx Med 2025;6:e69595